MyHep All is a generic hepatitis C drug from the Indian pharmaceutical company MyLan Pharmaceutical. It is a generic version of Epclusa, licensed by Gilead Sciences Inc. MyHep All is a combination of sofosbuvir 400 mg and velpatasvir 100 mg. MyLan Sofosbuvir + Velpatasvir was combined and marketed under the brand name MyHep All, a generic of Epclusa in India.
Most people can not even imagine having such a vital and expensive drug Epclusa. But now the generic drug Epclusa Sofosbuvir Velpatasvir is available in India. The drug, marketed by MyLan, is known worldwide for its affordable prices and quality products. The medications are highly recommended by professional doctors worldwide and are very beneficial to patients. MyHep All is made by a unique combination known for its high healing rate and affordable price. Indian generics always build trust and confidence in patients. The Indian MyHep All is an optimal drug for patients with hepatitis C, doctors around the world.
The price of MyHep All, compared to US drugs, is less than 100 times. MyHep All is now accessible to people around the world and affordable to people of all income groups. There is confidence in MyHep All, which has helped make it a leading drug for people with hepatitis C...Continue Reading